Effects of Drugs Affecting the Noradrenergic System on Convulsions in the Quaking Mouse
Overview
Authors
Affiliations
Handling-induced convulsions in the quaking mouse can be blocked by: phenobarbital, pentobarbital or phenytoin; postsynaptic alpha-adrenoceptor agonists (noradrenaline, phenylephrine, CRL 40028); presynaptic alpha-adrenoceptor blockers (yohimbine, mianserine); catecholamine liberating agent (amphetamine); noradrenaline reuptake inhibitors (cocaine, imipramine, desipramine). Moreover, the protective effect of yohimbine was antagonized by clonidine, prazosin or alpha-methylparatyrosine, and the protective effect of CRL 40028 was antagonized by prazosin but not by alpha-methyltyrosine. Drugs acting by other mechanisms (pilocarpine, atropine, trihexyphenidyl, (--)-5-HTP, methysergide, pimozide, clonidine, alpha-methyl DOPA, prazosin, isoprenaline, salbutamol) did not protect against convulsions. A slight protection was obtained with high doses of apomorphine and also with (+/-)-propranolol. This effect is probably not related to blockade of beta-adrenoceptors because the same effect was obtained with (+)propranolol. In young quaking mice, where susceptibility to convulsions is low, both postsynaptic alpha-adrenoceptor blockers and presynaptic alpha-adrenoceptor antagonist lowered the convulsive threshold. Thus, this seems to constitute an interesting model for the in vivo study of substances which affect the central alpha-adrenoceptors either pre- or postsynaptically.
Ciltas A, Ozdemir E, Gumus E, Taskiran A, Gunes H, Arslan G Neurochem Res. 2021; 47(2):305-314.
PMID: 34491515 DOI: 10.1007/s11064-021-03445-4.
Mechanisms of Psychiatric Comorbidities in Epilepsy.
Maguire J Curr Top Behav Neurosci. 2021; 55:107-144.
PMID: 33723802 DOI: 10.1007/7854_2020_192.
Genetic comparison of seizure control by norepinephrine and neuropeptide Y.
Weinshenker D, Szot P, Miller N, Rust N, Hohmann J, Pyati U J Neurosci. 2001; 21(19):7764-9.
PMID: 11567066 PMC: 6762890.
Maurin Y, Arbilla S, Dedek J, Lee C, Baumann N, Langer S Naunyn Schmiedebergs Arch Pharmacol. 1982; 320(1):26-33.
PMID: 6289135 DOI: 10.1007/BF00499067.
Bregman B, Le Saux F, Trottier S, Chauvel P, Maurin Y J Neural Transm. 1985; 63(2):109-18.
PMID: 3900290 DOI: 10.1007/BF01252611.